A number of key players are competing against each other in order to expand their existing customer base. Based on the revenues gained from the sales of rat model segment, the overall market was dominated by Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), and Envigo (U.K.). These players jointly accounted for a share of 66% of the total rat model market in 2015. Other players in this market include Horizon Discovery Group plc (U.K.), Transposagen Biopharmaceuticals, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), genOway, S.A. (France), Biomere (U.S.), Janvier Labs (France), and Transviragen, Inc. (U.S.).
Charles River Laboratories International, Inc., dominated the global rat model and services market with a share of around 42.0% in 2015. The company has aggressively adopted the acquisition strategy. It acquired seven companies in the last four years to improve its production and distribution capabilities as well as to strengthen its products and service portfolio. For instance, in 2016, it acquired Agilux Laboratories, Inc. (U.S.), a provider of bioanalytical services, drug metabolism and pharmacokinetic services, and pharmacology services; Blue Stream Laboratories, Inc. (U.S.), a contract research organization supporting the development of complex biologics and biosimilars; and WIL Research (U.S.), a provider of safety assessment and contract development and manufacturing (CDMO) services. The company has gained a major share in the rat model market on account of its comprehensive product portfolio, wide geographical reach; focus on organic growth strategies.
Envigo held a share of around 20.5% of the rat model and services market in 2015. The company aggressively follows expansion strategy to broaden its products and services portfolio and to achieve higher revenue. For instance, in January 2014, the company expanded its presence in India with the introduction of a new research model breeding facility located in Hyderabad. In addition, the company had expanded its specialty research production facility in Indianapolis and Livermore, U.S. in 2013. The company is also engaged in various promotional and marketing strategies such as participating in scientific seminars and trade shows, sponsoring events, and distributing brochures during visits.
Taconic Biosciences, Inc. accounted for a share of 3.5% of the global rat model and services market in 2015. The company focuses on developing unique models and has established an “Emerging Models Program.” This program is a collaborative effort between Principal Investigators (PI) and Taconic to improve and develop new and developing transgenic rodent models. The program is currently working on light-producing transgenic animals (LPTA). Taconic focuses on agreements, strategic partnerships, and distribution agreements to strengthen its presence in the market. The company enters into agreements and partnership with complementary companies and institutes that are involved in R&D activities and have requirements for rat models. These strategies are aimed at increasing its customer base for the rat models.
Other players operating in this market adopted the strategies of collaborations/agreements/partnerships/alliances, acquisitions, expansions, product launches, grants, licensing, and contracts to increase their customer base across geographies and establish a strong foothold in the market.
Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: [email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE